Sagility Limited
NSE: SAGILITYMarket Closed • NSE
Day range
52 week range
Sagility Limited closed at INR44.00 (+1.5%) on volume 1.21x its 20-day average, trading 23.99% below its 52-week high.
2026-Q1
Q1 FY2026 Financial Results
PAT moved -3.7% QoQ
2026-08-07
DIVIDEND Announced
Dividend - Re 0.10 Per Share
2025-11-12
DIVIDEND Announced
Interim Dividend - Re 0.05 Per Share
Revenue and PAT bars use independent scales to make their year-on-year direction readable.
Complete reported financial history · Values use the company's reporting currency
Hover over the chart for exact reported values. Percentage lines use the right-hand axis.
A 0–100 quantitative summary of reported fundamentals. Use the underlying financials and risks for context; the score is not a buy or sell recommendation.
Strengths
Low Debt Profile: Debt-to-Equity is comfortable at 0.11x
High Cash Flow Conversion: CFO/PAT averaged 2x over last 3 years
Risks
Subject to cyclical raw material and macro industry pressures
Bull case
Market Leadership: Established operational scale in Health Information Services.
Bear case
Macro Headwinds: Fluctuations in interest rates and sector-specific policy shifts could compress multiples.
Flip condition
Sustained quarterly EBITDA margin expansion above 20% would trigger an upgrade.
Complete dividend, bonus, split, rights and other action history
| Record date | Corporate action | Information | Announcement date | Ex-date |
|---|---|---|---|---|
| 07 Aug 2026 | Dividend | ₹0.10 / share | — | 07 Aug 2026 |
| 12 Nov 2025 | Dividend | ₹0.05 / share | — | 12 Nov 2025 |
Traded volume and delivery percentage across the latest 20 sessions
Compare valuation, latest quarterly performance and year-on-year growth
| Company name | Market cap ₹ Cr | P/E ratio | Dividend yield % | Quarterly sales ₹ Cr | Profit after tax ₹ Cr | Sales growth % | Profit growth % |
|---|---|---|---|---|---|---|---|
 Sun Pharmaceutical Industries LimitedSUNPHARMA Open analysis | ₹4.22L | 34.92 | 0.91% | ₹15,300.00 | ₹2,901.00 | +10.46% | +26.52% |
 Divi's Laboratories LimitedDIVISLAB Open analysis | ₹2.48L | 84.75 | 0.32% | ₹3,080.00 | ₹902.00 | +27.80% | +65.50% |
 Torrent Pharmaceuticals LimitedTORNTPHARM Open analysis | ₹1.77L | 74.39 | 0.82% | ₹4,128.00 | ₹389.00 | +41.90% | -21.89% |
 LENSKART SOLUTIONS LTDLENSKART Open analysis | ₹1.17L | 183.15 | 0.00% | ₹2,714.00 | ₹228.00 | +43.29% | +273.77% |
 Apollo Hospitals Enterprise LimitedAPOLLOHOSP Open analysis | ₹1.15L | 55.26 | 0.26% | ₹7,044.00 | ₹610.00 | +20.58% | +38.32% |
 Zydus Lifesciences LimitedZYDUSLIFE Open analysis | ₹1.11L | 24.91 | 0.09% | ₹8,017.00 | ₹990.00 | +21.95% | -34.91% |
 Laurus Labs LimitedLAURUSLABS Open analysis | ₹1.10L | 100.67 | 0.12% | ₹2,026.31 | ₹367.60 | +29.10% | +125.49% |
 Cipla LimitedCIPLA Open analysis | ₹1.05L | 31.20 | 0.99% | ₹7,119.00 | ₹786.00 | +2.33% | -39.16% |
Sagility Limited engages in the provision of business process management services to the healthcare and insurance industries in India, Jamaica, the Philippines, the United States, and Colombia. The company offers claims cost containment and management, member and provider engagement, enrolment, benefits plan building, payment integrity and billing, credentialing, clinical and case management, provider network operation services, analytics, front and back-office, administrative support provider, and data management services. It also provides utilization and care management, and population health management, as well as revenue cycle management functions, such as financial clearance, medical coding, billing, labs and durable medical equipment support, patient access and engagement, and accounts receivable follow-up services. In addition, it provides services to pharmacy benefit managers that manage prescription drugs for members under health insurance plans. Further, it offers various platforms, including document processing engine, genAI solutions for customer and member engagement, nurse assist, revenue cycle management, provider forward, enrolment and plan automation, and contract central. The company was formerly known as Sagility India Limited and changed its name to Sagility Limited in August 2025. The company was incorporated in 2021 and is based in Bengaluru, India. Sagility Limited operates as a subsidiary of Sagility B.V.
IndiaHealthcare
Is Sagility Limited Shariah compliant?
Sagility Limited is currently screened as Shariah Compliant under AAOIFI Shariah Standard No. 21. Business activities align with Shariah permissible sectors. Debt to Market Cap (5.39%) complies with AAOIFI threshold (≤ 33%).
What is Sagility Limited's current valuation relative to peers?
Sagility Limited trades at a P/E of 20.8x compared to the sector median of 37.6x, and a Price-to-Book of 2.1x.
Is the company financially healthy?
The company has a Debt-to-Equity ratio of 0.11x. Interest coverage is 12.8x.
What are the historical revenue and profit growth rates?
Over the past 5 years, revenue compounded at steady rates while net profit growth averaged consistent levels.
Market data is informational and may be delayed. Shariah screening follows the displayed methodology. This is not investment advice.
Market data may be delayed. Quote date: 2026-10-09. Financial figures relate to their stated reporting periods. This information is for research and is not a recommendation to buy or sell.